GPCR Assay Optimization with Chimeric G Proteins

GPCR assay optimization using chimeric G proteins enables improved signaling control and enhanced assay performance. At Sygnature Discovery, we engineer custom G protein constructs to redirect signaling through preferred pathways, increasing assay sensitivity and streamlining functional readouts across diverse GPCR targets. 

Introduction

Cell-based assays represent an important step in  understanding the functional effects of GPCR  modulation. Having access to high quality cellular tools is critical in driving forward these studies, providing reproducible data and clear insight when you need it most.  One of the major challenges faced when developing robust functional GPCR assays is defining the  optimal signaling components to ensure a reliable downstream assay and lead optimization. While some GPCRs signal amicably via endogenous host cell G proteins, other receptros benefit from  over-expression of a specific G protein to enable coupling and downstream signaling. Additionally, when developing assay systems for orphan receptors lack of information on the target’s signaling  mechanism can present a barrier to assay development and receptor de-orphanization.

This collaboration underscores the multifunctional nature of GDF15-GFRAL-RET, impacting pathways critical for cellular stress response and energy balance. Given its regulatory influence across broad physiological systems, this pathway presents new therapeutic opportunities, particularly in areas such as metabolic disorders and cancer.

G Protein
Characteristics
Assay Readout

SB-Gqα15

Wild-type SB-Gqα15

Calcium/ IP1 assays

SB-Gq/s

Gqα15 with c terminus optimized for Gs coupling

Calcium/ IP1 assays

SB-Gq/i

Gqα15 with c terminus optimized for Gi coupling

Calcium/ IP1 assays

SB-Gq/i (short)

Gqα15 with c terminus optimized for Gi coupling

Calcium/ IP1 assays

SB-Gqα12

Gqα15 with c terminus optimized for Gα12 coupling

Calcium/ IP1 assays

SB-Gqα13

Gqα15 with c terminus optimized for Gα13 coupling

Calcium/ IP1 assays

SB-Gs

Wild-type Gs

cAMP signaling assays

SB-Gs/q

Gs with c terminus optimized for Gq coupling

cAMP signaling assays

SB-Gs/i Gs

Gs with c terminus optimized for Gi coupling

cAMP signaling assays

SB-Gs/α12

Gs with c terminus optimized for G α12 coupling

cAMP signaling assays

SB-Gs/α13

Gs with c terminus optimized for G α13 coupling

cAMP signaling assays

Identifying Optimal G Protein Coupling

Using a comprehensive panel of G protein constructs Sygnature Discovery’s assay development team quickly iden­tifies optimal G proteins partners for your GPCR target, delivering robust functional assays for downstream drug discovery screening.

no G protein Gs Gs/i Gs/α12 Gs/α13 Gs/q 0 10 20 30 40 50 cAMP (nM per well) Vehicle 1 μM Agonist 10 μM Agonist
-10 -9 -8 -7 -6 -5 0 20 40 60 80 100 120 Log10 [Agonist] (M) cAMP (nM per well) No G protein Gs Gs/α13 Gs/q

Figure 1. G protein profiling. Identification of optimal G protein coupling partners for detection of robust functional GPCR responses. A range of G-proteins were co-transfected with taregt receptor to dentify optimal partner for downstream cAMP quantitation assay.

Convenient Assays Delivered

GPCR A GPCR A / Gq/i GPCR B GPCR B /Gq/i 0 500 1000 1500 RFU Vehicle Agonist
-12 -10 -8 -6 -4 0 500 1000 1500 2000 GPCR B Gq/i Log10 [Agonist] (M) RFU UT GPCR B Gq/i

Figure 2. Gi-coupled GPCR targets driven to signal via Gq pathway using chimeric G proteins to enable high-throughput screening using calcium mobilization assays.

CASE STUDY

Download the PDF: GPCR Assay Optimization with Chimeric G Proteins